Continuing effects of infectious diseases and concerns over renewed spread from variant strains
First written in FY2022-Q3. 3 of 7 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025ReframedAnnual report
「When infectious diseases and other illnesses spread, the group focuses on ensuring the safety of patients and employees by implementing disinfection measures at stores and facilities, replacing air-conditioning equipment and improving ventilation. However, the spread of infectious diseases and other illnesses may affect the group’s performance through fewer prescriptions as patients refrain from visiting nearby medical institutions and long-term prescriptions increase.」
The wording has been broadened from the previous description focused on COVID-19 and new variants to the general risk of infectious diseases and other illnesses spreading, and describes the impact on store operations of patients refraining from medical consultations, long-term prescriptions and employee infections. - FY2024-Q1MaterialisedAnnual report
「In May 2023, residents and facility employees contracted COVID-19. To prevent the spread of infection, occupancy promotion activities were temporarily suspended and the provision of medical services was restricted, at times resulting in sluggish monthly sales.」
COVID-19 actually materialised at primary-care homes in the form of infections, a temporary suspension of occupancy promotion activities, restrictions on medical services and sluggish monthly sales. - FY2023-Q3RestatedAnnual report
「During the fiscal year, the Japanese economy remained affected by COVID-19, while restrictions on activities were being eased」
The company continues to describe the ongoing impact of COVID-19. - FY2023-Q2MaterialisedAnnual report
「The company had initially been preparing to open the facility in December 2022, but construction has taken longer than expected due to the impact of COVID-19 and other factors, and residents are now expected to move in in early January.」
The impact of COVID-19 has materialised in the form of extended construction time for the senior-care facility and a delay in the timing of resident move-ins. - FY2023-Q1RestatedAnnual report
「During the fiscal year, the Japanese economy remained uncertain amid the continuing impact of COVID-19 and concerns over renewed spread of infection following the emergence of new variants, despite progress in vaccination.」
The company continues to describe the ongoing impact of COVID-19 and concerns over renewed spread caused by new variants. - FY2022RestatedAnnual report
「The spread of new infectious diseases, including COVID-19, may affect the company’s performance through fewer prescriptions as patients refrain from visiting nearby medical institutions and long-term prescriptions increase.」
The company continues to identify patients refraining from medical consultations, long-term prescriptions and employee infections caused by the spread of infectious diseases as risks affecting performance and store operations. - FY2022-Q3First statedAnnual report
「While the impact of COVID-19 continues and vaccination is progressing, signs of improvement have emerged in economic activity in Japan and overseas. However, the outlook remains uncertain amid concerns over renewed spread of infection following the emergence of new variants.」
The company describes the continuing impact of infectious diseases as an actual performance factor and identifies renewed spread caused by new variants as a future risk.